Communication of HIV viral load to guide sexual risk decisions with serodiscordant partners among San Francisco men who have sex with men

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 18, Issue 8, 2006, Pages 983-989

  Guzman, R ^a   Buchbinder, S ^a   Mansergh, G ^b   Vittinghoff, E ^c   Marks, G ^b   Wheeler, S ^a   Colfax, G N ^a  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DECISION MAKING; HEALTH STATUS; HEALTH SURVEY; HIGH RISK BEHAVIOR; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PLASMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; SEXUAL BEHAVIOR; SEXUALITY; UNITED STATES; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDIES; DECISION MAKING; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SAFE SEX; SAN FRANCISCO; SEXUAL PARTNERS; SOCIOECONOMIC FACTORS; TRUTH DISCLOSURE; VIRAL LOAD;

EID: 33749457845     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120500497908     Document Type: Article

References (54)

1. Bangsberg, D.R., Hecht, F.M., Charlebois, E.D., Zolopa, A.R., Holodniy, M., Sheiner, L., et al. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357-66.
2. Busch, M.P., Operskalski, E.A., Mosley, J.W., Lee, T.H., Henrard, D., Herman, S., et al. (1996). Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. Journal of Infectious Diseases, 174, 26-33.
3. Centers for Disease Control (1995). Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood-France, United Kingdom, and United States, January 1988-August 1994. Morbidity & Mortality Weekly Report, 44, 929-33.
4. Centers for Disease Control (2001). Outbreak of syphilis among men who have sex with men-Southern California, 2000. Morbidity & Mortality Weekly Report, 50, 117-20.
5. Chesney, M.A., Barrett, D.C., & Stall, R. (1998). Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. American Journal of Public Health, 88, 113-16.
6. Cohen Stuart, J.W., Wensing, A.M., Kovacs, C., Righart, M., De Jong, D., Kaye, S., et al. (2001). Transient relapses ('blips') of plasma HIV RNA levels during HAART are associated with drug resistance. Journal of Acquired Immune Deficiency Syndromes, 28, 105-13.
7. Colfax, G.N., Mansergh, G., Guzman, R., Vittinghoff, E., Marks, G., Rader, M., et al. (2001). Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison. Journal of Acquired Immune Deficiency Syndromes, 28, 373-79.
8. Coombs, R.W., Speck, C.E., Hughes, J.P., Lee, W., Sampoleo, R., Ross, S.O., et al. (1998). Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. Journal of Infectious Diseases, 177, 320-30.
9. Crepaz, N., Hart, T.A., & Marks, G. (2004). Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. Journal of the American Medical Association, 292, 224-36.
10. Di Mascio, M., Markowitz, M., Louie, M., Hogan, C., Hurley, A., Chung, C., et al. (2003). Viral blip dynamics during highly active antiretroviral therapy. Journal of Virology, 77, 12165-72.
11. Dickover, R.E., Garratty, E.M., Herman, S.A., Sim, M.S., Plaeger, S., Boyer, P.J., et al. (1996). Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. Journal of the American Medical Association, 275, 599-605.
12. Dukers, N.H., Goudsmit, J., De Wit, J.B., Prins, M., Weverling, G.J., & Coutinho, R.A. (2001). Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS, 15, 369-78.
13. Elford, J., Bolding, G., Maguire, M., & Sherr, L. (2000). Combination therapies for HIV and sexual risk behavior among gay men. Journal of Acquired Immune Deficiency Syndromes, 23, 266-71.
14. Elford, J., Bolding, G., & Sherr, L. (2002). High-risk sexual behaviour increases among London gay men between 1998 and 2001: what is the role of HIV optimism? AIDS, 16, 1537-44.
15. Fideli, U.S., Allen, S.A., Musonda, R., Trask, S., Hahn, B.H., Weiss, H., et al. (2001). Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa. AIDS Research and Human Retroviruses, 17, 901-10.
16. International Collaboration on HIV Optimism. (2003). Journal of Acquired Immune Deficiency Syndromes, 32, 545-50.
17. Jamieson, D.J., Sibailly, T.S., Sadek, R., Roels, T.H., Ekpini, E.R., Boni-Ouattara, E., et al. (2003). HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breastfeeding population in Cote d'Ivoire. Journal of Acquired Immune Deficiency Syndromes, 34, 430-36.
18. Kalichman, S.C., Cage, M., Barnett, T., Tharnish, P., Rompa, D., Austin, J., et al. (2001). Human immunodeficiency virus in semen and plasma: investigation of sexual transmission risk behavioral correlates. AIDS Research and Human Retroviruses, 17, 1695-1703.
19. Kalichman, S.C., Nachimson, D., Cherry, C., & Williams, E. (1998). AIDS treatment advances and behavioral prevention setbacks: preliminary assessment of reduced perceived threat of HIV-AIDS. Health Psychology, 17, 546-50.
20. Kalichman, S.C., Rompa, D., Austin, J., Luke, W., & Difonzo, K. (2001). Viral load, perceived infectivity, and unprotected intercourse. Journal of Acquired Immune Deficiency Syndromes, 28, 303-5.
21. Kalichman, S.C., Rompa, D., Cage, M., Austin, J., Luke, W., Barnett, T., et al. (2002). Sexual transmission risk perceptions and behavioural correlates of HIV concentrations in semen. AIDS Care, 14, 343-49.
22. Kalichman, S.C., Weinhardt, L., Difonzo, K., Austin, J., & Luke, W. (2002). Sensation seeking and alcohol use as markers of sexual transmission risk behavior in HIV-positive men. Annals of Behavioral Medicine , 24, 229-35.
23. Katz, M.H., Schwarcz, S.K., Kellogg, T.A., Klausner, J.D., Dilley, J.W., Gibson, S., et al. (2002). Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. American Journal of Public Health, 92, 388-94.
24. Kellogg, T., McFarland, W., & Katz, M. (1999). Recent increases in HIV seroconversion among repeat anonymous testers in San Francisco. AIDS, 13, 2303-4.
25. Kelly, J.A., Hoffman, R.G., Rompa, D., & Gray, M. (1998). Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex. AIDS, 12, F91-95.
26. Kim, A.A., Kent, C.K., & Klausner, J.D. (2002). Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000-2001. AIDS, 16, 1425-28.
27. Kim, A.A., Kent, C.K., & Klausner, J.D. (2003). Risk factors for rectal gonococcal infection amidst resurgence in HIV transmission. Sexually Transmitted Diseases, 30, 813-17.
28. Koblin, B.A., Chesney, M.A., Husnik, M.J., Bozeman, S., Celum, C.L., Buchbinder, S., et al. (2003). High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study. American Journal of Public Health, 93, 926-32.
29. Koblin, B.A., Torian, L.V., Guilin, V., Ren, L., Mackellar, D.A., & Valleroy, L.A. (2000). High prevalence of HIV infection among young men who have sex with men in New York City. AIDS, 14, 1793-1800.
30. Lee, T.H., Sakahara, N., Fiebig, E., Busch, M.P., O'Brien, T.R., & Herman, S.A. (1996). Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, 427-28.
31. Liuzzi, G., D'Offizi, G., Topino, S., Zaccarelli, M., Amendola, A., Capobianchi, M.R., et al. (2003). Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy. AIDS, 17, 1089-1092.
32. Lucas, G.M., Chaisson, R.E., & Moore, R.D. (1999). Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Annals of Internal Medicine, 131, 81-87.
33. Mansergh, G., Marks, G., Rader, M., Colfax, G.N., & Buchbinder, S. (2003). Rectal use of nonoxynol-9 among men who have sex with men. AIDS, 17, 905-9.
34. McNabb, J., Ross, J.W., Abriola, K., Turley, C., Nightingale, C.H., & Nicolau, D.P. (2001). Adherence to highly active antiretroviral therapy predicts virologic outcome at an innercity human immunodeficiency virus clinic. Clinical Infectious Diseases, 33, 700-5.
35. Mira, J.A., Macias, J., Nogales, C., Fernandez-Rivera, J., Garcia-Garcia, J.A., Ramos, A., et al. (2002). Transient rebounds of low-level viraemia among HIV-infected patients under HAART are not associated with virological or immunological failure. Antiviral Therapy, 7, 251-256.
36. Porco, T., Martin, J.N., Page-Shafer, K., Cheng, A., Charlebois, E., Grant, R.M., et al. (2004). Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS, 18, 81-88.
37. Quinn, T.C., Wawer, M.J., Sewankambo, N., Serwadda, D., LI, C., Wabwire-Mangen, F., et al. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal of Medicine, 342, 921-29.
38. Scheer, S., Chu, P.L., Klausner, J.D., Katz, M.H., & Schwarcz, S.K. (2001). Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. The Lancet, 357, 432-35.
39. Sethi, A.K., Celentano, D.D., Gange, S.J., Moore, R.D., & Gallant, J.E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases, 37, 1112-118.
40. Sklar, P.A., Ward, D.J., Baker, R.K., Wood, K.C., Gafoor, Z., & Alzola, C.F., et al. (2002). Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantification. AIDS, 16, 2035-41.
41. Stolte, I.G., Dukers, N.H., Geskus, R., Coutinho, R.A., & De Wit, J.B. (2004). Homosexual men change to risky sex when perceiving less threat of HIV/AIDS since availability of highly active antiretroviral therapy: a longitudinal study. AIDS, 18, 303-9.
42. Stueve, A., O'Donnell, L., Duran, R., San Doval, A., & Geier, J. (2002). Being high and taking sexual risks: findings from a multisite survey of urban young men who have sex with men. AIDS Education & Prevention, 14, 482-95.
43. Suarez, T.P., Kelly, J.A., Pinkerton, S.D., Stevenson, Y.L., Hayat, M., Smith, M.D., et al. (2001). Influence of a partner's HIV serostatus, use of highly active antiretroviral therapy, and viral load on perceptions of sexual risk behavior in a community sample of men who have sex with men. Journal of Acquired Immune Deficiency Syndromes, 28, 471-77.
44. Tabet, S.R., Krone, M.R., Paradise, M.A., Corey, L., Stamm, W.E., & Celum, C.L. (1998). Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM). AIDS, 12, 2041-48.
45. Tovanabutra, S., Robison, V., Wongtrakul, J., Sennum, S., Suriyanon, V., Kingkeow, D., et al. (2002). Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand. Journal of Acquired Immune Deficiency Syndromes, 29, 275-83.
46. Valleroy, L.A., Mackellar, D.A., Karon, J.M., Rosen, D.H., Mcfarland, W., Shehan, D.A., et al. (2000). HIV prevalence and associated risks in young men who have sex with men. Young Men's Survey Study Group. Journal of the American Medical Association, 284, 198-204.
47. Van De Ven, P., Kippax, S., Knox, S., Prestage, G., & Crawford, J. (1999). HIV treatments optimism and sexual behaviour among gay men in Sydney and Melbourne. AIDS, 13, 2289-94.
48. Van De Ven, P., Prestage, G., Crawford, J., Grulich, A., & Kippax, S. (2000). Sexual risk behaviour increases and is associted with HIV optimism among HIV-negative and HIV-positive gay men in Sydney over the 4 year period to February 2000. AIDS, 14, 2951-53.
49. Van De Ven, P., Rawstorne, P., Nakamura, T., Crawford, J., & Kippax, S. (2002). HIV treatments optimism is associated with unprotected anal intercourse with regular and with casual partners among Australian gay and homosexually active men. International Journal of STD & AIDS, 13, 181-83.
50. Vanable, P.A., Ostrow, D.G., Mckirnan, D.J., Taywaditep, K.J., & Hope, B.A. (2000). Impact of combination therapies on HIV risk perceptions and sexual risk among HIV-positive and HIV-negative gay and bisexual men. Health Psychology, 19, 134-45.
51. Vernazza, P.L., Eron, J.J., Fiscus, S.A., & Cohen, M.S. (1999). Sexual transmission of HIV: infectiousness and prevention. AIDS, 13, 155-66.
52. Vernazza, P.L., Gilliam, B.L., Dyer, J., Fiscus, S.A., Eron, J.J., Frank, A.C., et al. (1997). Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS, 11, 987-93.
53. Woody, G.E., Donnell, D., Seage, G.R., Metzger, D., Marmor, M., Koblin, B.A., et al. (1999). Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug and Alcohol Dependency, 53, 197-205.
54. Zuckerman, R.A., Whittington, W.L., Celum, C.L., Collis, T.K., Lucchetti, A.J., Sanchez, J.L., et al. (2004). Higher Concentration of HIV RNA in Rectal Mucosa Secretions than in Blood and Seminal Plasma, among Men Who Have Sex with Men, Independent of Antiretroviral Therapy. Journal of Infectious Diseases, 190, 156-61.